A multi-country study of prevalence and early childhood mortality among children with omphalocele

. 2020 Dec ; 112 (20) : 1787-1801. [epub] 20201017

Jazyk angličtina Země Spojené státy americké Médium print-electronic

Typ dokumentu časopisecké články, Research Support, N.I.H., Extramural, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/pmid33067932

Grantová podpora
5U01DD000491 NCBDD CDC HHS - United States
Instituto de Salud Carlos III
037062 Arkansas Biosciences Institute
AZV 17-29622A Czech Ministry of Health
CC999999 Intramural CDC HHS - United States
Ministry of Science and Innovation, of Spain
Fundación 1000 sobre Defectos Congénitos, of Spain
Direzione Diritti di cittadinanza e coesione sociale-Regione Toscana
Dutch Ministry of Welfare, Health and Sports
Dutch Ministry of Welfare, Health and Sports.
Public Health Wales

BACKGROUND: Omphalocele is the second most common abdominal birth defect and often occurs with other structural and genetic defects. The objective of this study was to determine omphalocele prevalence, time trends, and mortality during early childhood, by geographical region, and the presence of associated anomalies. METHODS: We conducted a retrospective study with 23 birth defect surveillance systems in 18 countries who are members of the International Clearinghouse for Birth Defects Surveillance and Research that submitted data on cases ascertained from 2000 through 2012, approximately 16 million pregnancies were surveyed that resulted in live births, stillbirths, or elective terminations of pregnancy for fetal anomalies (ETOPFA) and cases with omphalocele were included. Overall prevalence and mortality rates for specific ages were calculated (day of birth, neonatal, infant, and early childhood). We used Kaplan-Meier estimates with 95% confidence intervals (CI) to calculate cumulative mortality and joinpoint regression for time trend analyses. RESULTS: The prevalence of omphalocele was 2.6 per 10,000 births (95% CI: 2.5, 2.7) and showed no temporal change from 2000-2012 (average annual percent change = -0.19%, p = .52). The overall mortality rate was 32.1% (95% CI: 30.2, 34.0). Most deaths occurred during the neonatal period and among children with multiple anomalies or syndromic omphalocele. Prevalence and mortality varied by registry type (e.g., hospital- vs. population-based) and inclusion or exclusion of ETOPFA. CONCLUSIONS: The prevalence of omphalocele showed no temporal change from 2000-2012. Approximately one-third of children with omphalocele did not survive early childhood with most deaths occurring in the neonatal period.

Arkansas Center for Birth Defects Research and Prevention Fay W Boozman College of Public Health Department of Epidemiology University of Arkansas for Medical Sciences Little Rock Arkansas USA

Arkansas Center for Birth Defects Research and Prevention Fay W Boozman College of Public Health Department of Epidemiology University of Arkansas for Medical Sciences Little Rock Little Rock Arkansas USA

Arkansas Reproductive Health Monitoring System Arkansas Children's Hospital Little Rock Arkansas USA

Birth Defects Epidemiology and Surveillance Branch Texas Department of State Health Services Austin Texas USA

Department of Basic Sciences of Health School of Health Pontificia Universidad Javeriana Cali Cali Colombia

Department of Epidemiology Emory University Rollins School of Public Health Atlanta Georgia USA

Department of Genetics EUROCAT Northern Netherlands University of Groningen University Medical Center Groningen Groningen The Netherlands

Department of Medical Genetics Thomayer Hospital Prague Czech Republic

Department of Neonatology Soroka Medical Center Beer Sheva Israel

Division of Medical Genetics Department of Pediatrics University of Utah School of Medicine Salt Lake City Utah USA

ECEMC Instituto de Salud Carlos 3 Madrid Spain

ECLAMC Center for Medical Education and Clinical Research Buenos Aires Argentina

Genetics Department Hospital Universitario Dr Jose E Gonzalez Universidad Autonóma de Nuevo León Nuevo León Mexico

Health Services Management Research Centre Tabriz University of Medical Sciences Tabriz Iran

Human Genetics Institute Pontificia Universidad Javeriana Bogotá Colombia

Institute of Clinical Physiology National Research Council Fondazione Toscana Gabriele Monasterio Tuscany Registry of Congenital Defects Pisa Italy

International Center on Birth Defects International Clearinghouse for Birth Defects Surveillance and Research Rome Italy

Lombardy Congenital Anomalies Registry Cancer Registry Unit Fondazione IRCCS Istituto Nazionale dei tumori Milan Italy

Malformation Monitoring Centre Saxony Anhalt Medical Faculty Otto von Guericke University Magdeburg Germany

Malta Congenital Anomalies Registry Directorate for Health Information and Research Valletta Malta

Metropolitan Atlanta Congenital Defects Program National Center on Birth Defects and Developmental Disabilities Centers for Disease Control and Prevention Atlanta Georgia USA

National Board of Health and Welfare Stockholm Sweden

National Network of Congenital Anomalies of Argentina National Center of Medical Genetics National Administration of Laboratories and Health Institutes National Ministry of Health and Social Development Buenos Aires Argentina

Omni Net for Children International Charitable Fund Rivne Ukraine

REMAPAR Paris Registry of Congenital Malformations Inserm UMR 1153 Obstetrical Perinatal and Pediatric Epidemiology Research Team Center for Epidemiology and Statistics Sorbonne Paris Cité DHU Risks in Pregnancy Paris Descartes University Paris France

RYVEMCE Department of Genetics Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán Mexico City Mexico

Slovak Teratologic Information Centre Slovak Medical University Bratislava Slovakia

The Congenital Anomaly Register and Information Service for Wales Singleton Hospital Swansea Wales UK

Utah Birth Defect Network Bureau of Children with Special Health Care Needs Division of Family Health and Preparedness Utah Department of Health Salt Lake City Utah USA

Zobrazit více v PubMed

Parker SE, Mai CT, Canfield MA, et al. Updated National Birth Prevalence estimates for selected birth defects in the United States, 2004-2006. Birth Defects Res A Clin Mol Teratol. 2010;88(12):1008–1016. PubMed

Tan KH, Kilby MD, Whittle MJ, Beattie BR, Booth IW, Botting BJ. Congenital anterior abdominal wall defects in England and Wales 1987-93: retrospective analysis of OPCS data. Bmj. 1996;313(7062):903–906. PubMed PMC

Hemminki K, Saloniemi I, Kyyronen P, Kekomaki M. Gastroschisis and omphalocele in Finland in the 1970s: prevalence at birth and its correlates. J Epidemiol Community Health. 1982;36(4):289–293. PubMed PMC

Bryon-Scott R, Haan E, Chan A, Bower C, Scott H, Clark K. A population-based study of abdominal wall defects in South Australia and Western Australia. Paediatric and Perinatal Epidemiology. 1998;12:136–151. PubMed

Forrester MB, Merz RD. Epidemiology of abdominal wall defects, Hawaii, 1986-1997. Teratology. 1999;60(3):117–123. PubMed

Rankin J, Dillon E, Wright C. Congenital anterior abdominal wall defects in the north of England, 1986-1996: occurrence and outcome. Prenat Diagn. 1999;19(7):662–668. PubMed

Salihu HM, Pierre-Louis BJ, Druschel CM, Kirby RS. Omphalocele and gastroschisis in the State of New York, 1992-1999. Birth Defects Res A Clin Mol Teratol. 2003;67(9):630–636. PubMed

Marshall J, Salemi JL, Tanner JP, et al. Prevalence, Correlates, and Outcomes of Omphalocele in the United States, 1995-2005. Obstet Gynecol. 2015;126(2):284–293. PubMed

Springett A, Draper ES, Rankin J, et al. Birth prevalence and survival of exomphalos in England and Wales: 2005 to 2011. Birth Defects Res A Clin Mol Teratol. 2014;100(9):721–725. PubMed

Goldkrand JW, Causey TN, Hull EE. The changing face of gastroschisis and omphalocele in southeast Georgia. J Matern Fetal Neonatal Med. 2004;15(5):331–335. PubMed

European Network of Population-Based Registries for the Epidemiological Surveillance of Congenital Anomalies. Prevalence Charts and Tables. 2019; https://eu-rd-platform.jrc.ec.europa.eu/eurocat/eurocat-data/prevalence. Accessed February 4, 2020.

St Louis AM, Kim K, Browne ML, et al. Prevalence trends of selected major birth defects: A multi-state population-based retrospective study, United States, 1999 to 2007. Birth defects research. 2017;109(18):1442–1450. PubMed

Prefumo F, Izzi C. Fetal abdominal wall defects. Best practice & research Clinical obstetrics & gynaecology. 2014;28(3):391–402. PubMed

Kamata S, Ishikawa S, Usui N, et al. Prenatal diagnosis of abdominal wall defects and their prognosis. J PediatrSurg. 1996;31(2):267–271. PubMed

Tsakayannis DE, Zurakowski D, Lillehei CW. Respiratory insufficiency at birth: a predictor of mortality for infants with omphalocele. J Pediatr Surg. 1996;31(8):1088–1090; discussion 1090-1081. PubMed

Biard JM, Wilson RD, Johnson MP, et al. Prenatally diagnosed giant omphaloceles: short- and long-term outcomes. Prenat Diagn. 2004;24(6):434–439. PubMed

Vermeij-Keers C, Hartwig NG, van der Werff JF. Embryonic development of the ventral body wall and its congenital malformations. Semin Pediatr Surg. 1996;5(2):82–89. PubMed

Frolov P, Alali J, Klein MD. Clinical risk factors for gastroschisis and omphalocele in humans: a review of the literature. Pediatric surgery international. 2010;26(12):1135–1148. PubMed

Reefhuis J, Honein MA. Maternal age and non-chromosomal birth defects, Atlanta--1968-2000: teenager or thirty-something, who is at risk? Birth Defects Res A Clin Mol Teratol. 2004;70(9):572–579. PubMed

Waller DK, Shaw GM, Rasmussen SA, et al. Prepregnancy obesity as a risk factor for structural birth defects. ArchPediatrAdolescMed. 2007;161(8):745–750. PubMed

Agopian A, Marengo L, Mitchell LE. Descriptive epidemiology of nonsyndromic omphalocele in Texas, 1999-2004. Am J Med Genet A. 2009;149a(10):2129–2133. PubMed

Duong HT, Hoyt AT, Carmichael SL, et al. Is maternal parity an independent risk factor for birth defects? Birth Defects Res A Clin Mol Teratol. 2012;94(4):230–236. PubMed PMC

Mac Bird T, Robbins JM, Druschel C, Cleves MA, Yang S, Hobbs CA. Demographic and environmental risk factors for gastroschisis and omphalocele in the National Birth Defects Prevention Study. J Pediatr Surg. 2009;44(8):1546–1551. PubMed

Feldkamp ML, Srisukhumbowornchai S, Romitti PA, et al. Self-reported maternal cigarette smoke exposure during the periconceptional period and the risk for omphalocoele. Paediatric and perinatal epidemiology. 2014;28(1):67–73. PubMed PMC

Lin S, Munsie JPW, Herdt-Losavio ML, et al. Maternal asthma medication use and the risk of selected birth defects. Pediatrics. 2012;129(2):e317–e324. PubMed PMC

Alwan S, Reefhuis J, Rasmussen SA, Olney RS, Friedman JM. Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects. The New England journal of medicine. 2007;356(26):2684–2692. PubMed

Riley MM, Halliday JL, Lumley JM. Congenital malformations in Victoria, Australia, 1983-95: an overview of infant characteristics. J Paediatr Child Health. 1998;34(3):233–240. PubMed

Doyle PE, Beral V, Botting B, Wale CJ. Congenital malformations in twins in England and Wales. J Epidemiol Community Health. 1991;45(1):43–48. PubMed PMC

Mastroiacovo P, Castilla EE, Arpino C, et al. Congenital malformations in twins: An international study. American Journal of Medical Genetics. 1999;83:117–124. PubMed

Hwang PJ, Kousseff BG. Omphalocele and gastroschisis: an 18-year review study. Genet Med. 2004;6(4):232–236. PubMed

Kirby RS. The prevalence of selected major birth defects in the United States. Semin Perinatol. 2017;41(6):338–344. PubMed

Kirby RS, Marshall J, Tanner JP, et al. Prevalence and correlates of gastroschisis in 15 states, 1995 to 2005. Obstetrics and gynecology. 2013;122(2 Pt 1):275–281. PubMed PMC

Bugge M, Holm NV. Abdominal wall defects in Denmark, 1970-89. PaediatrPerinatEpidemiol. 2002;16(1):73–81. PubMed

Allman R, Sousa J, Walker MW, Laughon MM, Spitzer AR, Clark RH. The epidemiology, prevalence and hospital outcomes of infants with gastroschisis. Journal Of Perinatology. 2016;36:901. PubMed

Bugge M, Drachmann G, Kern P, et al. Abdominal Wall Defects in Greenland 1989-2015. Birth defects research. 2017;109(11):836–842. PubMed

Calzolari E, Bianchi F, Dolk H, Milan M, Group EW. Omphalocele and gastroschisis in Europe: a survey of 3 million births 1980-1990. Am J Medical Genetics. 1995;58:187–194. PubMed

Benjamin B, Wilson GN. Anomalies associated with gastroschisis and omphalocele: analysis of 2825 cases from the Texas Birth Defects Registry. J Pediatr Surg. 2014;49(4):514–519. PubMed

Stoll C, Alembik Y, Dott B, Roth MP. Omphalocele and gastroschisis and associated malformations. Am J Med Genet A. 2008;146a(10):1280–1285. PubMed

Conner P, Vejde JH, Burgos CM. Accuracy and impact of prenatal diagnosis in infants with omphalocele. Pediatric surgery international. 2018;34(6):629–633. PubMed PMC

Corey KM, Hornik CP, Laughon MM, McHutchison K, Clark RH, Smith PB. Frequency of anomalies and hospital outcomes in infants with gastroschisis and omphalocele. Early human development. 2014;90(8):421–424. PubMed PMC

Brantberg A, Blaas HG, Haugen SE, Eik-Nes SH. Characteristics and outcome of 90 cases of fetal omphalocele. Ultrasound Obstet Gynecol. 2005;26(5):527–537. PubMed

Heider AL, Strauss RA, Kuller JA. Omphalocele: clinical outcomes in cases with normal karyotypes. Am J Obstet Gynecol. 2004;190(1):135–141. PubMed

Porter A, Benson CB, Hawley P, Wilkins-Haug L. Outcome of fetuses with a prenatal ultrasound diagnosis of isolated omphalocele. Prenat Diagn. 2009;29(7):668–673. PubMed

Cohen-Overbeek TE, Tong WH, Hatzmann TR, et al. Omphalocele: comparison of outcome following prenatal or postnatal diagnosis. Ultrasound Obstet Gynecol. 2010;36(6):687–692. PubMed

Raymond SL, Downard CD, St Peter SD, et al. Outcomes in omphalocele correlate with size of defect. J Pediatr Surg. 2018. PubMed

Akinkuotu AC, Sheikh F, Olutoye OO, et al. Giant omphaloceles: surgical management and perinatal outcomes. J Surg Res. 2015;198(2):388–392. PubMed

Sakonidou S, Ali K, Farmer I, Hickey A, Greenough A. Mortality and short-term morbidity in infants with exomphalos. Pediatr Int. 2018;60(5):438–441. PubMed

Fratelli N, Papageorghiou AT, Bhide A, Sharma A, Okoye B, Thilaganathan B. Outcome of antenatally diagnosed abdominal wall defects. Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology. 2007;30(3):266–270. PubMed

Deng K, Qiu J, Dai L, et al. Perinatal mortality in pregnancies with omphalocele: data from the Chinese national birth defects monitoring network, 1996–2006. 2014;14(1):160. PubMed PMC

Hijkoop A, Peters NCJ, Lechner RL, et al. Omphalocele: from diagnosis to growth and development at 2 years of age. Archives of disease in childhood Fetal and neonatal edition. 2019;104(1):F18–f23. PubMed

Groen H, Bouman K, Pierini A, et al. Stillbirth and neonatal mortality in pregnancies complicated by major congenital anomalies: Findings from a large European cohort. Prenatal diagnosis. 2017;37(11):1100–1111. PubMed

The Centre of the International Clearinghouse for Birth Defects Surveillance and Research. Annual Report 2014:10.

Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Statistics in medicine. 2000;19(3):335–351. PubMed

Byron-Scott R, Haan E, Chan A, Bower C, Scott H, Clark K. A population-based study of abdominal wall defects in South Australia and Western Australia. Paediatr Perinat Epidemiol. 1998;12(2):136–151. PubMed

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...